4DN Phase II (2020-2025)
Yvonne Fondufe-Mittendorf, Ph.D.
|Van Andel Institute|
|Steve Henikoff, Ph.D.||Fred Hutchinson Cancer Center|
|Thoru Pederson, Ph.D.||University of Massachusetts|
|Abby Dernburg, Ph.D.||University of California Berkeley|
|Carolyn Larabell, Ph.D.||University of California Berkeley|
|Genevieve Almouzni, Ph.D.||Institut Curie, Paris, France|
4DN Phase I (2015-2020)
Marisa Bartolomei, Ph.D.
Professor of Cell and Developmental Biology
University of Pennsylvania, Perelman School of Medicine
J. Michael Cerry, Ph.D.
Department of Genetics, Stanford University
Tom Gingeras, Ph.D.
Cold Spring Harbor Laboratory
Gary Karpen, Ph.D.
Division Director/Life Sciences Division
Lawrence Berkeley National Laboratory
Department of Energy
Mathieu Lupien, Ph.D.
Scientist, Assistant Professor
Princess Margaret Cancer Centre / University Health Network
University of Toronto, Department of Medical Biophysics
Aviv Regev, Ph.D.
Professor of Biology
Core Member, Broad Institute
Investigator, Howard Hughes Medical Institute
Massachusetts Institute of Technology
John Stamatoyannopoulos, M.D., D.Sc.
Associate Professor of Genome Sciences and of Medicine
University of Washington
Michael Hawrylycz, Ph.D.
Aaron Straight, Ph.D.
Jane Skok, Ph.D.
NYU School of Medicine
Maria-Elena Torres-Padilla, Ph.D.
|Group Leader|| |
Helmholtz Zentrum München
German Research Center for Environmental Health
Institute of Epigenetics and Stem Cells